Dimethyllysergamide
Dimethyllysergamide
Dimethyllysergamide (also known as DAM-57) is a chemical compound belonging to the ergoline family. It is a derivative of lysergic acid and is structurally related to lysergic acid diethylamide (LSD). Dimethyllysergamide is of interest in the field of psychopharmacology due to its potential psychoactive properties.
Chemical Structure and Properties
Dimethyllysergamide is characterized by its ergoline backbone, which is a tetracyclic structure. The compound is a lysergamide, meaning it is an amide of lysergic acid. The chemical structure of Dimethyllysergamide includes two methyl groups attached to the nitrogen atom of the amide group, distinguishing it from other lysergamides such as LSD, which has ethyl groups instead.
Pharmacology
The pharmacological effects of Dimethyllysergamide are not as well-studied as those of LSD. However, it is believed to interact with the serotonin receptors in the brain, similar to other compounds in the ergoline family. This interaction is thought to be responsible for its potential psychoactive effects.
Synthesis
The synthesis of Dimethyllysergamide involves the chemical modification of lysergic acid. The process typically includes the formation of the amide bond between lysergic acid and dimethylamine. This synthesis requires careful control of reaction conditions to ensure the correct formation of the desired product.
Potential Uses and Research
Research into Dimethyllysergamide is limited, but it is of interest for its potential use in psychedelic therapy and as a tool for understanding the neurobiology of consciousness. Studies on similar compounds have shown promise in treating conditions such as depression and post-traumatic stress disorder (PTSD).
Legal Status
The legal status of Dimethyllysergamide varies by country. In many places, it is not specifically scheduled, but it may be considered an analogue of LSD and thus subject to similar legal restrictions under analogue laws.
Related Pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
